# Novo Nordisk a S: Form 20-F for the period ended Dec 31, 2023

- Company: [Novo Nordisk a S](/companies/nvo.md) (CIK 353278)
- Form: 20-F
- Filed: 2024-01-31
- Accepted by EDGAR: Jan 31, 2024, 06:51 ET
- Period: 2023-12-31
- Accession: 0001628280-24-002635
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/nvo-20231231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-01-01 to 2023-12-31 | DKK 232.26bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2023-01-01 to 2023-12-31 | DKK 35.77bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2023-01-01 to 2023-12-31 | DKK 196.50bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2023-01-01 to 2023-12-31 | DKK 102.57bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2023-01-01 to 2023-12-31 | DKK 20.99bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2023-01-01 to 2023-12-31 | DKK 83.68bn | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2023-01-01 to 2023-12-31 | DKK 18.62 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2023-01-01 to 2023-12-31 | DKK 18.67 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2023-01-01 to 2023-12-31 | DKK 108.91bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-01-01 to 2023-12-31 | DKK 25.81bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2023-12-31 | DKK 14.39bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2023-12-31 | DKK 139.65bn | ifrs-full:CurrentAssets |
| Total assets | at 2023-12-31 | DKK 314.49bn | ifrs-full:Assets |
| Current liabilities | at 2023-12-31 | DKK 169.66bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2023-12-31 | DKK 207.93bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2023-12-31 | DKK 106.56bn | ifrs-full:Equity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/nvo-20231231.htm

Filed Jan 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-002635. Last ingested by Listed: Nov 5, 2026, 13:49 ET. No prices; not investment advice.